F. Meniai-Merzouki
Papers
1
Total Citations
25
H-Index
1
About
F. Meniai-Merzouki is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic radiotherapy for intracranial tumors. Her major contribution lies in the optimization of hypofractionated stereotactic radiation treatment (hFSRT) for intracranial meningiomas, demonstrating through a landmark 2018 study that this regimen achieves excellent local control with a favorable toxicity profile. In this work, involving 126 patients and 136 meningiomas treated over nearly a decade, she established hFSRT as a safe and effective primary or adjuvant therapy, particularly for tumors near critical structures. This highly cited paper (25 citations) has shaped clinical guidelines by providing robust evidence for fractionated approaches over single-session radiosurgery in select cases. Her research directly impacts treatment decision-making, offering patients a non-invasive option that balances tumor control with quality of life. Meniai-Merzouki’s work continues to influence the evolution of precision radiotherapy, making her a key voice in neuro-oncology and stereotactic technique development.
Research Focus
Key Achievements
Top Papers
- 1